Pulmonx Corporation (LUNG)
NASDAQ: LUNG · IEX Real-Time Price · USD
7.92
-0.05 (-0.63%)
At close: Jul 19, 2024, 4:00 PM
7.87
-0.05 (-0.63%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $307.42 million as of July 22, 2024. Its market cap has decreased by -36.52% in one year.
Market Cap
307.42M
Enterprise Value
231.63M
1-Year Change
-36.52%
Ranking
Category
Stock Price
$7.92
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $616.87M to $307.42M, a decrease of -50.16%. That is a compound annual growth rate of -16.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 307.40M | -37.06% |
| Dec 29, 2023 | 488.40M | 54.85% |
| Dec 30, 2022 | 315.40M | -73.30% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 299.10% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 313.66M |
| Nyxoah | 312.68M |
| OraSure Technologies | 310.63M |
| MacroGenics | 308.16M |
| Sutro Biopharma | 307.96M |
| Jasper Therapeutics | 305.33M |
| Opthea | 305.22M |
| Enanta Pharmaceuticals | 303.29M |